Integrum
49.9 SEK +0.4%1 investor is following this company
Integrum is a medical technology company. The company is developing systems for skeletal anchored prostheses based on the developed OPRA implant system, which later are being resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of many patients with amputation. The company was founded in 1998 and is headquartered in Mölndal.
Revenue
-
EBIT %
-
P/E
216.96
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
INTEG B
Daily low / high price
49 / 50.6
SEK
Market cap
967.9M SEK
Turnover
654.74K SEK
Volume
13K
Financial calendar
Interim report
29.08.2024
General meeting
25.09.2024
Interim report
04.12.2024
Interim report
03.03.2025
Annual report
03.06.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Rickard Brånemark | 33.2 % | 49.1 % |
Nordnet Pensionförsäkring | 8.1 % | 6.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Integrum AB: Integrum has carried out a directed new issue of 961,539 series B shares, raising proceeds of approximately SEK 50 million
Integrum AB: Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools